Agenus Inc. (AGEN)
NASDAQ: AGEN · Real-Time Price · USD
3.890
-0.200 (-4.89%)
At close: Apr 28, 2026, 4:00 PM EDT
3.914
+0.024 (0.62%)
After-hours: Apr 28, 2026, 4:22 PM EDT

Agenus Revenue

In the year 2025, Agenus had annual revenue of $114.20M with 10.37% growth. Agenus had revenue of $34.20M in the quarter ending December 31, 2025, with 27.45% growth.

Revenue (ttm)
$114.20M
Revenue Growth
+10.37%
P/S Ratio
1.33
Revenue / Employee
$1,409,827
Employees
81
Market Cap
149.37M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025114.20M10.73M10.37%
Dec 31, 2024103.46M-52.85M-33.81%
Dec 31, 2023156.31M58.29M59.47%
Dec 31, 202298.02M-197.64M-66.85%
Dec 31, 2021295.67M207.50M235.34%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Alpha Cognition 10.22M
Fate Therapeutics 6.65M
Alps Group 3.74M
Humacyte 2.04M
Oramed Pharmaceuticals 2.00M
Molecular Partners AG 856.30K
Spruce Biosciences 697.00K
Revenue Rankings